Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9


Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 107

PDF Downloaded: 89


Reverse transcriptase inhibitors: Potential drug delivery combating COVID-19


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : S V Deshpande*, D P Mali

Volume : 7, Issue : 4, Year : 2020

Article Page : 161-165

https://doi.org/10.18231/j.ijpca.2020.026



Suggest article by email

Abstract

As the development of any drug and that too antiviral drug always requires time, in this Corona virus pandemic no specific drugs have been approved for coronavirus disease 2019 (COVID-19) till date. Therefore, assessment, analysis and use of currently available antiviral drugs become a challenge for medical field for a timely response to the current pandemic. Here, we have tried review anti CoV-2 potencies of available reverse transcriptase antiviral drugs. Several clinical trials are going on worldwide on variety of options but no specific solution in the form of vaccine or drug developed.

Keywords: COVID 19, SARS, Remdesivir.



How to cite : Deshpande S V , Mali D P , Reverse transcriptase inhibitors: Potential drug delivery combating COVID-19. Int J Pharm Chem Anal 2020;7(4):161-165


Copyright © 2020 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)